Citigroup’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Citigroup’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-80,474	Closed	-$692K	–	5825
2023 Q1	$692K	Sell	80,474 -802	-1%	-$6.61K	﹤0.01%	2864
2022 Q4	$700K	Sell	81,276 -300	-0.4%	-$2.42K	﹤0.01%	2931
2022 Q3	$489K	Buy	81,576 +16,762	+26%	+$91K	﹤0.01%	3250
2022 Q2	$350K	Buy	+64,814	New	+$349K	﹤0.01%	3493

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup's VECT Position: Q2 2023 in Review

Citigroup sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 80,474 shares — an estimated $692K sold.

Citigroup first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $700K in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Citigroup reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Citigroup sold 80,474 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $692K.
Citigroup first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
Citigroup's VectivBio Holding AG Ordinary Shares position peaked at $700K in Q4 2022.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.